Skip to content
value.today
Deals / Acquisition

Celgene acquired by Bristol Myers Squibb for 74 Billion USD

Deal value
$74.0 B
Year
2019
Stake
100%

Summary

Celgene acquired by Bristol Myers Squibb for 74 Billion USD.

Celgene is a Bio-Pharmaceutical company and headquarters is in New Jersey, USA.

Bristol-Myers Squibb is USA based health care and pharmaceutical multi-national company. Headquarters is in New York, USA.

Details

Type
Acquisition
Buyer
Bristol-Myers Squibb
Buyer headquarters
USA
Year
2019
Stake acquired
100%
Website
bms.com